-
1
-
-
33846620518
-
Celecoxib as adjunctive therapy in schizophrenia: a double-blind, randomized and placebo-controlled trial
-
Akhondzadeh S., Tabatabaee M., Amini H., Abhari S.A.A., Abbasi S.H., Behnam B. Celecoxib as adjunctive therapy in schizophrenia: a double-blind, randomized and placebo-controlled trial. Schizophrenia Research 2007, 90:179-185.
-
(2007)
Schizophrenia Research
, vol.90
, pp. 179-185
-
-
Akhondzadeh, S.1
Tabatabaee, M.2
Amini, H.3
Abhari, S.A.A.4
Abbasi, S.H.5
Behnam, B.6
-
2
-
-
0034057150
-
Decreased in vitro production of interferon-gamma and interleukin-2 in whole blood of patients with schizophrenia during treatment
-
Arolt V., Rothermundt M., Wandinger K.P., Kirchner H. Decreased in vitro production of interferon-gamma and interleukin-2 in whole blood of patients with schizophrenia during treatment. Molecular Psychiatry 2000, 5:150-158.
-
(2000)
Molecular Psychiatry
, vol.5
, pp. 150-158
-
-
Arolt, V.1
Rothermundt, M.2
Wandinger, K.P.3
Kirchner, H.4
-
3
-
-
0036139673
-
Cytokine profiles in schizophrenic patients treated with risperidone: a 3-month follow-up study
-
Cazzullo C.L., Sacchetti E., Galluzzo A., Panariello A., Adorni A., Pegoraro M., Bosis S., Colombo F., Trabattoni D., Zagliani A., et al. Cytokine profiles in schizophrenic patients treated with risperidone: a 3-month follow-up study. Progress in Neuro-Psychopharmacology & Biological Psychiatry 2002, 26:33-39.
-
(2002)
Progress in Neuro-Psychopharmacology & Biological Psychiatry
, vol.26
, pp. 33-39
-
-
Cazzullo, C.L.1
Sacchetti, E.2
Galluzzo, A.3
Panariello, A.4
Adorni, A.5
Pegoraro, M.6
Bosis, S.7
Colombo, F.8
Trabattoni, D.9
Zagliani, A.10
-
4
-
-
33845615926
-
Effects of olanzapine on plasma levels of catecholamine metabolites, cytokines, and brain-derived neurotrophic factor in schizophrenic patients
-
Hori H., Yoshimura R., Yamada Y., Ikenouchi A., Mitoma M., Ida Y., Nakamura J. Effects of olanzapine on plasma levels of catecholamine metabolites, cytokines, and brain-derived neurotrophic factor in schizophrenic patients. International Clinical Psychopharmacology 2007, 22:21-27.
-
(2007)
International Clinical Psychopharmacology
, vol.22
, pp. 21-27
-
-
Hori, H.1
Yoshimura, R.2
Yamada, Y.3
Ikenouchi, A.4
Mitoma, M.5
Ida, Y.6
Nakamura, J.7
-
5
-
-
0027260588
-
Mice that lack the interferon-gamma receptor have profoundly altered responses to infection with Bacillus Calmette-Guérin and subsequent challenge with lipopolysaccharide
-
Kamijo R., Le J., Shapiro D., Havell E.A., Huang S., Aguet M., Bosland M., Vilcek J. Mice that lack the interferon-gamma receptor have profoundly altered responses to infection with Bacillus Calmette-Guérin and subsequent challenge with lipopolysaccharide. Journal of Experimental Medicine 1993, 178:1435-1440.
-
(1993)
Journal of Experimental Medicine
, vol.178
, pp. 1435-1440
-
-
Kamijo, R.1
Le, J.2
Shapiro, D.3
Havell, E.A.4
Huang, S.5
Aguet, M.6
Bosland, M.7
Vilcek, J.8
-
6
-
-
0023606101
-
The Positive and Negative Syndrome Scale (PANSS) for schizophrenia
-
Kay S.R., Fiszbein A., Opler L.A. The Positive and Negative Syndrome Scale (PANSS) for schizophrenia. Schizophrenia Bulletin 1987, 13:261-276.
-
(1987)
Schizophrenia Bulletin
, vol.13
, pp. 261-276
-
-
Kay, S.R.1
Fiszbein, A.2
Opler, L.A.3
-
7
-
-
0035543540
-
Effect of risperidone on serum cytokines
-
Kim D.J., Kim W., Yoon S.J., Go H.J., Choi B.M., Jun T.Y., Kim Y.K. Effect of risperidone on serum cytokines. International Journal of Neuroscience 2001, 111:11-19.
-
(2001)
International Journal of Neuroscience
, vol.111
, pp. 11-19
-
-
Kim, D.J.1
Kim, W.2
Yoon, S.J.3
Go, H.J.4
Choi, B.M.5
Jun, T.Y.6
Kim, Y.K.7
-
8
-
-
10944266569
-
Th1, Th2 and Th3 cytokine alteration in schizophrenia
-
Kim Y.K., Myint A.M., Lee B.H., Han C.S., Lee H.J., Kim D.J., Leonhard B.E. Th1, Th2 and Th3 cytokine alteration in schizophrenia. Progress in Neuro-psychopharmacology & Biological Psychiatry 2004, 28:1129-1134.
-
(2004)
Progress in Neuro-psychopharmacology & Biological Psychiatry
, vol.28
, pp. 1129-1134
-
-
Kim, Y.K.1
Myint, A.M.2
Lee, B.H.3
Han, C.S.4
Lee, H.J.5
Kim, D.J.6
Leonhard, B.E.7
-
9
-
-
0035062021
-
Interleukin-10 and the interleukin-10 receptor
-
Moore K.W., de Waal Malefyt R., Coffman R.L., O'Garra A. Interleukin-10 and the interleukin-10 receptor. Annual Review of Immunology 2001, 19:683-765.
-
(2001)
Annual Review of Immunology
, vol.19
, pp. 683-765
-
-
Moore, K.W.1
de Waal Malefyt, R.2
Coffman, R.L.3
O'Garra, A.4
-
10
-
-
0032819293
-
Old drug, new tricks: haloperidol inhibits secretion of proinflammatory cytokines
-
Moots R.J., Al-Saffar Z., Hutchinson D., Golding S.P., Young S.P., Bacon P.A., McLaughlin P.J. Old drug, new tricks: haloperidol inhibits secretion of proinflammatory cytokines. Annals of the Rheumatic Diseases 1999, 58:585-587.
-
(1999)
Annals of the Rheumatic Diseases
, vol.58
, pp. 585-587
-
-
Moots, R.J.1
Al-Saffar, Z.2
Hutchinson, D.3
Golding, S.P.4
Young, S.P.5
Bacon, P.A.6
McLaughlin, P.J.7
-
11
-
-
0029928417
-
The expanding universe of T-cell subsets: Th1, Th2 and more
-
Mosmann T.R., Sad S. The expanding universe of T-cell subsets: Th1, Th2 and more. Immunology Today 1996, 17:138-146.
-
(1996)
Immunology Today
, vol.17
, pp. 138-146
-
-
Mosmann, T.R.1
Sad, S.2
-
12
-
-
33847714348
-
Immunologische Aspekte bei schizophrenen Stoerungen
-
Mueller N., Schwarz M.J. Immunologische Aspekte bei schizophrenen Stoerungen. Nervenarzt 2007, 78:253-263.
-
(2007)
Nervenarzt
, vol.78
, pp. 253-263
-
-
Mueller, N.1
Schwarz, M.J.2
-
13
-
-
0033665649
-
The immune system and schizophrenia. An integrative view
-
Mueller N., Riedel M., Gruber R., Ackenheil M., Schwarz M.J. The immune system and schizophrenia. An integrative view. Annals of the New York Academy of Sciences 2000, 917:456-467.
-
(2000)
Annals of the New York Academy of Sciences
, vol.917
, pp. 456-467
-
-
Mueller, N.1
Riedel, M.2
Gruber, R.3
Ackenheil, M.4
Schwarz, M.J.5
-
14
-
-
0036272768
-
Beneficial antipsychotic effects of celecoxib add-on therapy compared to risperidone alone in schizophrenia
-
Mueller N., Riedel M., Scheppach C., Brandstaetter B., Sokullu S., Krampe K., Ulmschneider M., Engel R.R., Moeller H.J., Schwarz M.J. Beneficial antipsychotic effects of celecoxib add-on therapy compared to risperidone alone in schizophrenia. American Journal of Psychiatry 2002, 159:1029-1034.
-
(2002)
American Journal of Psychiatry
, vol.159
, pp. 1029-1034
-
-
Mueller, N.1
Riedel, M.2
Scheppach, C.3
Brandstaetter, B.4
Sokullu, S.5
Krampe, K.6
Ulmschneider, M.7
Engel, R.R.8
Moeller, H.J.9
Schwarz, M.J.10
-
15
-
-
40349111658
-
Monocytic, Th1 and Th2 cytokine alterations in the pathophysiology of schizophrenia
-
Na K.S., Kim Y.K. Monocytic, Th1 and Th2 cytokine alterations in the pathophysiology of schizophrenia. Neuropsychobiology 2007, 56:55-63.
-
(2007)
Neuropsychobiology
, vol.56
, pp. 55-63
-
-
Na, K.S.1
Kim, Y.K.2
-
16
-
-
34248159908
-
Differences in lymphocyte electron transport gene expression levels between subjects with bipolar disorder and normal controls in response to glucose deprivation stress
-
Naydenov A.V., MacDonald M.L., Ongur D., Konradi C. Differences in lymphocyte electron transport gene expression levels between subjects with bipolar disorder and normal controls in response to glucose deprivation stress. Archives of General Psychiatry 2007, 64:555-564.
-
(2007)
Archives of General Psychiatry
, vol.64
, pp. 555-564
-
-
Naydenov, A.V.1
MacDonald, M.L.2
Ongur, D.3
Konradi, C.4
-
17
-
-
47249134619
-
Strategies for use of IL-10 or its antagonists in human disease
-
O'Garra A., Barrat F.J., Castro A.G., Vicari A., Hawrylowicz C. Strategies for use of IL-10 or its antagonists in human disease. Immunological Reviews 2008, 223:114-131.
-
(2008)
Immunological Reviews
, vol.223
, pp. 114-131
-
-
O'Garra, A.1
Barrat, F.J.2
Castro, A.G.3
Vicari, A.4
Hawrylowicz, C.5
-
18
-
-
0033396319
-
At issue: schizophrenia and rheumatoid arthritis: the negative association revisited
-
Oken R.J., Schulzer M. At issue: schizophrenia and rheumatoid arthritis: the negative association revisited. Schizophrenia Bulletin 1999, 25:625-638.
-
(1999)
Schizophrenia Bulletin
, vol.25
, pp. 625-638
-
-
Oken, R.J.1
Schulzer, M.2
-
19
-
-
0034495201
-
Effects of antipsychotic drugs on cytokine networks
-
Pollmaecher T., Haack M., Schuld A., Kraus T., Hinze-Selch D. Effects of antipsychotic drugs on cytokine networks. Journal of Psychiatric Research 2000, 34:369-382.
-
(2000)
Journal of Psychiatric Research
, vol.34
, pp. 369-382
-
-
Pollmaecher, T.1
Haack, M.2
Schuld, A.3
Kraus, T.4
Hinze-Selch, D.5
-
20
-
-
33750701761
-
Decreased T cellular immune response in schizophrenic patients
-
Riedel M., Spellmann I., Schwarz M.J., Strassnig M., Sikorski C., Moeller H.J., Muller N. Decreased T cellular immune response in schizophrenic patients. Journal of Psychiatric Research 2007, 41:3-7.
-
(2007)
Journal of Psychiatric Research
, vol.41
, pp. 3-7
-
-
Riedel, M.1
Spellmann, I.2
Schwarz, M.J.3
Strassnig, M.4
Sikorski, C.5
Moeller, H.J.6
Muller, N.7
-
21
-
-
0033792004
-
Cytokine production in unmedicated and treated schizophrenic patients
-
Rothermundt M., Arolt V., Leadbeater J., Peters M., Rudolf S., Kirchner H. Cytokine production in unmedicated and treated schizophrenic patients. NeuroReport 2000, 11:3385-3388.
-
(2000)
NeuroReport
, vol.11
, pp. 3385-3388
-
-
Rothermundt, M.1
Arolt, V.2
Leadbeater, J.3
Peters, M.4
Rudolf, S.5
Kirchner, H.6
-
22
-
-
0030722084
-
Antiviral activity of tumor necrosis factor (TNF) is mediated via p55 and p75 TNF receptors
-
Ruby J., Bluethmann H., Peschon J.J. Antiviral activity of tumor necrosis factor (TNF) is mediated via p55 and p75 TNF receptors. The Journal of Experimental Medicine 1997, 186:1591-1596.
-
(1997)
The Journal of Experimental Medicine
, vol.186
, pp. 1591-1596
-
-
Ruby, J.1
Bluethmann, H.2
Peschon, J.J.3
-
23
-
-
0023907493
-
Interleukin-2: inception, impact, and implications
-
Smith K.A. Interleukin-2: inception, impact, and implications. Science 1988, 240:1169-1176.
-
(1988)
Science
, vol.240
, pp. 1169-1176
-
-
Smith, K.A.1
-
24
-
-
33646010307
-
Evaluating the comparability of gene expression in blood and brain
-
Sullivan P.F., Fan C., Perou C.M. Evaluating the comparability of gene expression in blood and brain. American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics 2006, 141:261-268.
-
(2006)
American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics
, vol.141
, pp. 261-268
-
-
Sullivan, P.F.1
Fan, C.2
Perou, C.M.3
-
25
-
-
34548032814
-
Antibodies to Toxoplasma gondii in patients with schizophrenia: a meta-analysis
-
Torrey E.F., Bartko J.J., Lun Z.R., Yolken R.H. Antibodies to Toxoplasma gondii in patients with schizophrenia: a meta-analysis. Schizophrenia Bulletin 2007, 33:729-736.
-
(2007)
Schizophrenia Bulletin
, vol.33
, pp. 729-736
-
-
Torrey, E.F.1
Bartko, J.J.2
Lun, Z.R.3
Yolken, R.H.4
-
26
-
-
0023491364
-
Anti-cachectin/TNF monoclonal antibodies prevent septic shock during lethal bacteraemia
-
Tracey K.J., Fong Y., Hesse D.G., Manoque K.R., Lee A.T., Kuo G.C., Lowry S.F., Cerami A. Anti-cachectin/TNF monoclonal antibodies prevent septic shock during lethal bacteraemia. Nature 1987, 330:662-664.
-
(1987)
Nature
, vol.330
, pp. 662-664
-
-
Tracey, K.J.1
Fong, Y.2
Hesse, D.G.3
Manoque, K.R.4
Lee, A.T.5
Kuo, G.C.6
Lowry, S.F.7
Cerami, A.8
-
27
-
-
9644302458
-
Interleukin-10 in viral disease and cancer: exciting the labyrinth?
-
Vicari A.P., Trinchieri G. Interleukin-10 in viral disease and cancer: exciting the labyrinth?. Immunological Reviews 2004, 202:223-236.
-
(2004)
Immunological Reviews
, vol.202
, pp. 223-236
-
-
Vicari, A.P.1
Trinchieri, G.2
-
28
-
-
4444240323
-
Changes in serum interleukin-2, -6, and -8 levels before and during treatment with risperidone and haloperidol: relationship to outcome in schizophrenia
-
Zhang X.Y., Zhou D.F., Cao L.Y., Zhang P.Y., Wu G.Y., Shen Y.C. Changes in serum interleukin-2, -6, and -8 levels before and during treatment with risperidone and haloperidol: relationship to outcome in schizophrenia. Journal of Clinical Psychiatry 2004, 65:940-947.
-
(2004)
Journal of Clinical Psychiatry
, vol.65
, pp. 940-947
-
-
Zhang, X.Y.1
Zhou, D.F.2
Cao, L.Y.3
Zhang, P.Y.4
Wu, G.Y.5
Shen, Y.C.6
|